EGF61 Polymorphism Predicts Complete Pathologic Response to Cetuximab-Based Chemoradiation Independent of KRAS Status in Locally Advanced Rectal Cancer Patients

✍ Scribed by Hu-Lieskovan, S.; Vallbohmer, D.; Zhang, W.; Yang, D.; Pohl, A.; Labonte, M. J.; Grimminger, P. P.; Holscher, A. H.; Semrau, R.; Arnold, D.; Dellas, K.; Debucquoy, A.; Haustermans, K.; Machiels, J.-P. H.; Sempoux, C.; Rodel, C.; Bracko, M.; Velenik, V.; Lenz, H.-J.

• Book ID: 121346079
• Publisher: American Association for Cancer Research
• Year: 2011
• Tongue: English
• Weight: 241 KB
• Volume: 17
• Category: Article
• ISSN: 1078-0432
• DOI: 10.1158/1078-0432.CCR-10-2666